Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions

dc.contributor.buuauthorUsta, Mehmet
dc.contributor.buuauthorDilek, Kamil
dc.contributor.buuauthorYavuz, Mahmut
dc.contributor.buuauthorErsoy, Alparslan
dc.contributor.buuauthorGüllülü, Mustafa
dc.contributor.buuauthorYurtkuran, Mustafa Abbas
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.contributor.scopusid7005030712tr_TR
dc.contributor.scopusid56005080200tr_TR
dc.contributor.scopusid7006244754tr_TR
dc.contributor.scopusid35612977100tr_TR
dc.contributor.scopusid6602684544tr_TR
dc.contributor.scopusid7003389525tr_TR
dc.date.accessioned2021-12-01T07:58:29Z
dc.date.available2021-12-01T07:58:29Z
dc.date.issued2001-03
dc.identifier.citationUsta, M. vd. (2001). "Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions". Clinical Nephrology, 55(3), 260-262.tr_TR
dc.identifier.endpage262tr_TR
dc.identifier.issn0301-0430
dc.identifier.issue3tr_TR
dc.identifier.pubmed11316250tr_TR
dc.identifier.scopus2-s2.0-0035105081tr_TR
dc.identifier.startpage260tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/22919
dc.identifier.volume55tr_TR
dc.identifier.wos000172184000014tr_TR
dc.indexed.pubmedPubmedtr_TR
dc.indexed.scopusScopustr_TR
dc.indexed.wosSCIEtr_TR
dc.language.isoentr_TR
dc.publisherDustritr_TR
dc.relation.journalClinical Nephrologytr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccesstr_TR
dc.subjectConvertingtr_TR
dc.subjectEnzymetr_TR
dc.subjectInhibitortr_TR
dc.subjectUrology & nephrologytr_TR
dc.subject.emtreeRenintr_TR
dc.subject.emtreeAngiotensintr_TR
dc.subject.emtreeAngiotensin 2 receptor antagonisttr_TR
dc.subject.emtreeDipeptidyl carboxypeptidase inhibitortr_TR
dc.subject.emtreeEnalapriltr_TR
dc.subject.emtreeLosartantr_TR
dc.subject.emtreeDrug effecttr_TR
dc.subject.emtreeAdulttr_TR
dc.subject.emtreeAlport syndrometr_TR
dc.subject.emtreeClinical articletr_TR
dc.subject.emtreeControlled studytr_TR
dc.subject.emtreeDiabetic nephropathytr_TR
dc.subject.emtreeGlomerulonephritistr_TR
dc.subject.emtreeDrug selectivitytr_TR
dc.subject.emtreeDrug specificitytr_TR
dc.subject.emtreeEssential hypertensiontr_TR
dc.subject.emtreeFemaletr_TR
dc.subject.emtreeFocal glomerulosclerosistr_TR
dc.subject.emtreeGlomerulopathytr_TR
dc.subject.emtreeGlomerulosclerosistr_TR
dc.subject.emtreeMembranous glomerulonephritistr_TR
dc.subject.emtreeGlomerulus filtrationtr_TR
dc.subject.emtreeGlomerulus filtration ratetr_TR
dc.subject.emtreeImmunoglobulin A nephropathytr_TR
dc.subject.emtreeHumantr_TR
dc.subject.emtreeHistopathologytr_TR
dc.subject.emtreeImmunosuppressive treatmenttr_TR
dc.subject.emtreeKidney biopsytr_TR
dc.subject.emtreeKidney diseasetr_TR
dc.subject.emtreeKidney functiontr_TR
dc.subject.emtreeKidney plasma flowtr_TR
dc.subject.emtreeLettertr_TR
dc.subject.emtreeMaletr_TR
dc.subject.emtreeMembranoproliferative glomerulonephritistr_TR
dc.subject.emtreeProtectiontr_TR
dc.subject.emtreeProteinuriatr_TR
dc.subject.emtreeRenin angiotensin aldosterone systemtr_TR
dc.subject.emtreeRisk factortr_TR
dc.subject.meshHumanstr_TR
dc.subject.meshAntihypertensive agentstr_TR
dc.subject.meshFemaletr_TR
dc.subject.meshGlomerulonephritistr_TR
dc.subject.meshKidney glomerulustr_TR
dc.subject.meshLosartantr_TR
dc.subject.meshMaletr_TR
dc.subject.meshProteinuriatr_TR
dc.subject.meshReceptors, angiotensintr_TR
dc.subject.scopusRenin Angiotensin Aldosterone System; Angiotensin Receptor Antagonists; Diabetic Nephropathiestr_TR
dc.subject.wosUrology & nephrologytr_TR
dc.titleAnti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesionstr_TR
dc.typeLetter
dc.wos.quartileQ2tr_TR

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections